• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cognyte Elects Two New Board Members to Strengthen Expertise and Drive Growth

    2/18/25 8:00:00 AM ET
    $ALLT
    $BLRX
    $CGEN
    $CGNT
    Computer Communications Equipment
    Telecommunications
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ALLT alert in real time by email

    Announcement reflects company's commitment to augment Board of Directors with industry-experienced executives from both the government and software sectors

    Cognyte Software Ltd. (NASDAQ:CGNT) ("Cognyte"), a global leader in investigative analytics software, today announced the appointment of two new members to its Board of Directors. Matthew O'Neill and Nurit Benjamini will join the board on March 1, 2025, and March 31, 2025, respectively, reflecting the company's commitment to add independent directors from the government and software sectors. Richard Nottenburg will be stepping down from his board position effective March 31, 2025.

    Having served with the United States Secret Service for over two decades, Mr. O'Neill brings significant law enforcement, government, financial crimes and security experience, along with established relationships within these communities. Ms. Benjamini has more than 20 years of experience as CFO in leading software companies, overseeing financial reporting for a diverse group of U.S.-listed technology firms. Together, these two directors are well-aligned with Cognyte's strategic goals of growing its business and expanding its North American presence.

    "We are pleased to welcome Matthew O'Neill and Nurit Benjamini as our two newest board members," said Earl Shanks, Chairman of Cognyte's Board of Directors. "These latest appointments reflect our commitment to further strengthen the board with deep industry and business experience. Matthew brings significant domain expertise in security and a strong understanding of U.S. federal agency practices and procedures. Nurit has extensive experience working in the software sector, where she has led finance, operations, legal and strategic initiatives across different roles and domains. We are excited to have both Matthew and Nurit with us as we continue to drive consistent long-term growth at Cognyte."

    "We sincerely appreciate Richard's valuable contributions and guidance during his tenure on the Cognyte board," added Mr. Shanks. "Richard played a key role in establishing Cognyte as an independent company with market leading technology and a solid foundation for sustainable growth."

    Mr. O'Neill served until December 2023 as the Deputy Special Agent in Charge of Cyber Operations at the United States Secret Service, where he directed the agency's global cyber investigative strategies and oversaw efforts to dismantle transnational criminal networks. During his tenure, he served as the Director of the Asset Forfeiture Branch and as the Director of the Global Investigative Operations Center, where he established the Secret Service's first agencywide criminal investigative fusion center. Mr. O'Neill holds certifications from Carnegie Mellon University and American University and earned his Bachelor of Science degree from James Madison University. He currently serves as Co-Founder and Partner at 5OH Consulting LLC.

    Ms. Benjamini is a Partner and CFO at F2 Venture Capital, bringing over 20 years of experience as a CFO for leading software companies, including CrazyLabs Ltd., Wix (NASDAQ:WIX), CopperGate Communications Ltd. and Compugen (NASDAQ:CGEN). Throughout her career, Ms. Benjamini has played a pivotal role in leading technology companies through fundraising, M&A and IPO processes. Currently, she serves as an external director at Caesarstone Ltd. (NASDAQ:CSTE), having previously served as a board member of BioLineRx (NASDAQ:BLRX) and Allot Ltd. (NASDAQ:ALLT). Ms. Benjamini holds a Bachelor of Arts degree in economics and business and a Master of Business Administration degree in finance, both from Bar Ilan University, Israel.

    About Cognyte Software Ltd.

    Cognyte Software Ltd. is a global leader in investigative analytics software that empowers a variety of government and other organizations with Actionable Intelligence for a Safer World™. Our open interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making. Hundreds of customers rely on our solutions to accelerate and conduct investigations and derive insights, with which they identify, neutralize, and tackle threats to national security and address different forms of criminal and terror activities. Learn more at www.cognyte.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250218582211/en/

    Investor Relations Contact:

    Dean Ridlon

    Cognyte Software

    IR@cognyte.com

    Get the next $ALLT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALLT
    $BLRX
    $CGEN
    $CGNT

    CompanyDatePrice TargetRatingAnalyst
    Wix.com Ltd.
    $WIX
    5/14/2026$60.00Outperform → Sector Perform
    RBC Capital Mkts
    Wix.com Ltd.
    $WIX
    5/14/2026$66.00Buy → Neutral
    Citigroup
    Wix.com Ltd.
    $WIX
    5/14/2026$54.00Overweight → Equal Weight
    Wells Fargo
    Wix.com Ltd.
    $WIX
    4/7/2026Mkt Outperform → Mkt Perform
    Citizens
    Compugen Ltd.
    $CGEN
    4/7/2026$6.00Buy
    Lake Street
    Wix.com Ltd.
    $WIX
    4/3/2026$96.00Buy → Neutral
    UBS
    Wix.com Ltd.
    $WIX
    4/2/2026$96.00Buy → Neutral
    UBS
    Wix.com Ltd.
    $WIX
    3/27/2026$91.00Neutral → Underweight
    Analyst
    More analyst ratings

    $ALLT
    $BLRX
    $CGEN
    $CGNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP Customer Success & Ops Lelah Noam sold $178,080 worth of Ordinary Shares (21,000 units at $8.48), decreasing direct ownership by 11% to 176,250 units (SEC Form 4)

    4 - Allot Ltd. (0001365767) (Issuer)

    6/2/26 11:45:43 AM ET
    $ALLT
    Computer Communications Equipment
    Telecommunications

    Chief Product Officer Shteiman Mark sold $82,430 worth of Ordinary shares (11,000 units at $7.49), decreasing direct ownership by 5% to 214,000 units (SEC Form 4)

    4 - Allot Ltd. (0001365767) (Issuer)

    5/26/26 7:27:27 AM ET
    $ALLT
    Computer Communications Equipment
    Telecommunications

    Managing Director, APAC Cullen David Vincent sold $11,029 worth of Ordinary Shares (7,025 units at $1.57), decreasing direct ownership by 91% to 675 units (SEC Form 4)

    4 - Caesarstone Ltd. (0001504379) (Issuer)

    5/21/26 4:10:05 PM ET
    $CSTE
    Building Materials
    Industrials

    $ALLT
    $BLRX
    $CGEN
    $CGNT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Willow Raises $7M Seed to Ensure Enterprises Can Fully Oversee and Govern Autonomous Agents

    Already used by thousands of employees at website building platform Wix, Willow equips enterprises with 360-degree visibility of an AI agent's activity, while securely controlling how agents access internal systems, data, and enterprise toolsHERZLIYA, Israel, June 4, 2026 /PRNewswire/ -- Willow, a pioneering agentic access platform has emerged from stealth with $7 million in seed funding to enable enterprises to safely adopt AI agents across the workplace without impeding innovation. The round was led by Hetz Ventures, following early angel investment from Wix Co-Founder and CEO Avishai Abrahami and President Nir Zohar, who backed Willow at its earliest stage. The funding will be used to enh

    6/4/26 8:00:00 AM ET
    $WIX
    Computer Software: Programming Data Processing
    Technology

    Wix Named as Partner in OpenAI's Codex Enterprise Launch for Sites

    Codex users can now connect to Wix Headless to access business solutions through MCP and APIs to turn AI-generated designs into fully operational businesses Wix has been named a partner in OpenAI's Codex Enterprise launch, serving as an official plugin to build online. The partnership connects OpenAI's agentic platform directly to Wix Headless, enabling anyone to go from a business idea to a live, revenue-ready operation without leaving Codex. Through a dedicated Wix plugin, users can combine the frontend UI built with Codex and instantly connect it to Wix Headless, Wix's full suite of backend business capabilities including Wix Stores, Wix Bookings, Wix Events, CMS, Payments and more. A s

    6/3/26 9:00:00 AM ET
    $WIX
    Computer Software: Programming Data Processing
    Technology

    Cognyte Reports First Quarter Fiscal Year 2027 Financial Results

    Reports double-digit revenue growth, and profitability growing significantly faster than revenue Reiterates fiscal 2027 outlook Cognyte Software Ltd. (NASDAQ:CGNT) (the "Company," "Cognyte," "we," "us" and "our"), a global leader in software-driven technology for investigative analytics, today announced results for the three months ended April 30, 2026 ("Q1 FYE27"). Financial Summary for Three Months Ended April 30, 2026 Q1 FYE27 Revenue was $105.5 million, up approximately 10.4% compared to the same period last year, reflecting a continuing healthy demand environment. Q1 FYE27 GAAP operating income was $4.4 million, doubling from operating income of $2.2 million in the same per

    6/3/26 7:00:00 AM ET
    $CGNT
    Computer Software: Prepackaged Software
    Technology

    $ALLT
    $BLRX
    $CGEN
    $CGNT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Topline Capital Partners, Lp bought $6,114,211 worth of shares (969,631 units at $6.31), increasing direct ownership by 12% to 9,020,184 units (SEC Form 4)

    4 - Cognyte Software Ltd. (0001824814) (Issuer)

    9/12/24 6:40:00 PM ET
    $CGNT
    Computer Software: Prepackaged Software
    Technology

    See Explanation in Footnotes Topline Capital Management, Llc bought $6,114,211 worth of shares (969,631 units at $6.31) (SEC Form 4)

    4 - Cognyte Software Ltd. (0001824814) (Issuer)

    9/12/24 6:31:23 PM ET
    $CGNT
    Computer Software: Prepackaged Software
    Technology

    $ALLT
    $BLRX
    $CGEN
    $CGNT
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Wix.com Ltd.

    SCHEDULE 13G/A - Wix.com Ltd. (0001576789) (Subject)

    6/5/26 9:51:39 AM ET
    $WIX
    Computer Software: Programming Data Processing
    Technology

    SEC Form 6-K filed by Cognyte Software Ltd.

    6-K - Cognyte Software Ltd. (0001824814) (Filer)

    6/3/26 7:07:00 AM ET
    $CGNT
    Computer Software: Prepackaged Software
    Technology

    SEC Form 6-K filed by BioLineRx Ltd.

    6-K - BioLineRx Ltd. (0001498403) (Filer)

    5/27/26 7:19:57 AM ET
    $BLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLT
    $BLRX
    $CGEN
    $CGNT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for APHEXDA issued to BIOLINERX, LTD.

    Submission status for BIOLINERX, LTD.'s drug APHEXDA (ORIG-1) with active ingredient MOTIXAFORTIDE has changed to 'Approval' on 09/08/2023. Application Category: NDA, Application Number: 217159, Application Classification: Type 1 - New Molecular Entity

    9/11/23 2:15:50 PM ET
    $BLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLT
    $BLRX
    $CGEN
    $CGNT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wix.com downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded Wix.com from Outperform to Sector Perform and set a new price target of $60.00

    5/14/26 8:51:51 AM ET
    $WIX
    Computer Software: Programming Data Processing
    Technology

    Wix.com downgraded by Citigroup with a new price target

    Citigroup downgraded Wix.com from Buy to Neutral and set a new price target of $66.00

    5/14/26 8:51:24 AM ET
    $WIX
    Computer Software: Programming Data Processing
    Technology

    Wix.com downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Wix.com from Overweight to Equal Weight and set a new price target of $54.00

    5/14/26 8:51:24 AM ET
    $WIX
    Computer Software: Programming Data Processing
    Technology

    $ALLT
    $BLRX
    $CGEN
    $CGNT
    Leadership Updates

    Live Leadership Updates

    View All

    SolarEdge Appoints Maoz Sigron as Chief Financial Officer

    SolarEdge Technologies, Inc. ("SolarEdge" or the "Company") (NASDAQ:SEDG), a global leader in smart energy technology, announced today the appointment of Mr. Maoz Sigron as the Company's new Chief Financial Officer (CFO), effective May 31, 2026. Maoz Sigron succeeds Mr. Asaf Alperovitz, who is stepping down from the role to pursue another professional opportunity outside of the industry. Asaf will remain with the Company through June 9, 2026 to assist with a smooth handover. Mr. Sigron has over 20 years of financial and operational experience across global organizations, with a strong track record in governance, M&A, capital markets, budgeting and operational discipline in NASDAQ- and TAS

    5/11/26 7:00:00 AM ET
    $ALLT
    $SEDG
    $SSYS
    Computer Communications Equipment
    Telecommunications
    Semiconductors
    Technology

    Compugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of Directors

    HOLON, Israel, Feb. 12, 2026 /PRNewswire/ -- Compugen Ltd. (NASDAQ:CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered by AI/ML, today announced the appointment of Michele Holcomb, Ph.D., as a new independent director, effective February 11, 2026. "On behalf of Compugen's Board of Directors, I am delighted to welcome Michele to the Board," said Anat Cohen-Dayag, Ph.D., Executive Chair, Compugen. "Michele brings more than three decades of experience spanning the biotech, pharmaceuticals and healthcare services industries. Her unique blend of strategic insights, corporate development, innovation and firsthand operation

    2/12/26 7:00:00 AM ET
    $CGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    PayPal and Wix Advance Strategic Relationship to Deliver Unified Payments Experience for Merchants

    PayPal integrates with Wix Payments, providing a consolidated view for merchants to streamline payment management, enhance conversions and meet growing demand for flexible payment options  NEW YORK – Wix.com Ltd. (NASDAQ:WIX), the leading SaaS website builder platform globally1, today announced an expansion of its partnership with PayPal Holdings Inc. (NASDAQ:PYPL), bringing additional online payment options to merchants through Wix Payments. Now available as a built-in part of Wix Payments, this provides U.S.-based merchants a unified, seamless experience that simplifies backend operations and ultimately supports higher checkout conversion.  With this deeper integration, PayPal is now ava

    7/24/25 9:00:00 AM ET
    $PYPL
    $WIX
    Diversified Commercial Services
    Industrials
    Computer Software: Programming Data Processing
    Technology

    $ALLT
    $BLRX
    $CGEN
    $CGNT
    Financials

    Live finance-specific insights

    View All

    Cognyte Reports First Quarter Fiscal Year 2027 Financial Results

    Reports double-digit revenue growth, and profitability growing significantly faster than revenue Reiterates fiscal 2027 outlook Cognyte Software Ltd. (NASDAQ:CGNT) (the "Company," "Cognyte," "we," "us" and "our"), a global leader in software-driven technology for investigative analytics, today announced results for the three months ended April 30, 2026 ("Q1 FYE27"). Financial Summary for Three Months Ended April 30, 2026 Q1 FYE27 Revenue was $105.5 million, up approximately 10.4% compared to the same period last year, reflecting a continuing healthy demand environment. Q1 FYE27 GAAP operating income was $4.4 million, doubling from operating income of $2.2 million in the same per

    6/3/26 7:00:00 AM ET
    $CGNT
    Computer Software: Prepackaged Software
    Technology

    BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update

    - Announced first patient dosed in Phase 1/2a clinical trial of GLIX1 for treatment of glioblastoma (GBM) -- Announced new GLIX1 data demonstrating potent anti-tumor effect in GBM across multiple in-vivo studies, including a temozolomide (TMZ)-resistant patient-derived xenograft model -- Management to host conference call today, May 27, at 8:30 am EDT -TEL AVIV, Israel, May 27, 2026 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ:BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its unaudited financial results for the quarter ended March 31, 2026, and provided a corporate update. "Since our last quarterly upda

    5/27/26 7:00:00 AM ET
    $BLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cognyte to Announce First Quarter FYE27 Financial Results on June 3, 2026

    Cognyte Software Ltd. (NASDAQ:CGNT), a global leader in investigative analytics software, today announced it will conduct a conference call on Wednesday, June 3, 2026, at 8:30 a.m. ET to review its first quarter financial results for the quarter ending April 30, 2026. An earnings press release will be issued prior to the conference call. A real-time webcast of the conference call with presentation slides will be available in the Investor Relations section of Cognyte's website. Those interested in participating in the question-and-answer session need to register here to receive the dial-in numbers and unique PIN to access the call seamlessly. It is recommended that you join 10 minutes prio

    5/26/26 7:00:00 AM ET
    $CGNT
    Computer Software: Prepackaged Software
    Technology

    $ALLT
    $BLRX
    $CGEN
    $CGNT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Allot Ltd.

    SC 13G - Allot Ltd. (0001365767) (Subject)

    11/18/24 9:00:22 AM ET
    $ALLT
    Computer Communications Equipment
    Telecommunications

    Amendment: SEC Form SC 13G/A filed by Caesarstone Ltd.

    SC 13G/A - Caesarstone Ltd. (0001504379) (Subject)

    11/14/24 6:21:59 AM ET
    $CSTE
    Building Materials
    Industrials

    Amendment: SEC Form SC 13G/A filed by Cognyte Software Ltd.

    SC 13G/A - Cognyte Software Ltd. (0001824814) (Subject)

    11/12/24 4:07:25 PM ET
    $CGNT
    Computer Software: Prepackaged Software
    Technology